Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) Meeting Abstract

  

Authors:	Ryan, C. J.; Smith, M. R.; de Bono, J. S.; Molina, A.; Logothetis, C.; De Souza, P. L.; Fizazi, K.; Mainwaring, P. N.; Rodriguez, J. M. P.; Ng, S.; Carles, J.; Mulders, P.; Kheoh, T. S.; Griffin, T. W.; Small, E. J.; Scher, H. I.; Rathkopf, D. E.
Abstract Title:	Interim analysis (IA) results of COU-AA-302, a randomized, phase III study of abiraterone acetate (AA) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
Meeting Title:	48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	30
Issue:	18 Suppl.
Meeting Dates:	2012 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2012-06-20
Language:	English
ACCESSION:	WOS:000318026200024
PROVIDER:	wos
DOI:	10.1200/jco.2012.30.15_suppl.LBA4518
Notes:	--- - Meeting Abstract: LBA4518 - 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - JUN 01-05, 2012 - Chicago, IL - S - "Source: Wos"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/43057